Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2000
09/27/2000CN1268058A The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases
09/27/2000CN1267546A Medicine for rheumatism and its preparation
09/27/2000CN1267527A Pain-relieving arthralgia dredging Chinese medicine preparation
09/27/2000CN1056844C Dioxide pyrrolo-pyrrolo derivatives
09/27/2000CN1056836C 3,5-disubstituted and 3,4,5-trisubstituted 2-isoxazolines and isoxazoles and producing process thereof and their use as medicaments
09/27/2000CN1056771C Tincture for external use for dispelling wind and removing dampness
09/26/2000US6124358 Pharmaceutical composition containing rhein or diacerhein with improved bioavailability
09/26/2000US6124332 Metalloproteinase inhibitors
09/26/2000US6124329 Metalloproteinase inhibitors
09/26/2000US6124316 Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/26/2000CA2190011C Method for reduction of headache pain
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055189A1 Dalda analogs and their use
09/21/2000WO2000055183A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055154A1 Modified amino-acid amides as cgrp antagonists
09/21/2000WO2000055153A1 Amide derivatives
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000055120A1 Amide derivatives
09/21/2000WO2000055114A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000WO2000055109A1 Lipoxin compounds and their use
09/21/2000WO2000055072A2 Aerosol metering valve
09/21/2000WO2000054797A2 Pharmaceutical compositions comprising tgf-beta
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054793A1 Pharmaceutical composition comprising mixed aqueous extract of anemarrhena rhizoma and phellodendron bark for analgesic and anti-inflammation
09/21/2000WO2000054780A2 Corticosteroid formulation
09/21/2000WO2000054778A1 Preventive or therapeutic agents for inflammatory dermatoses
09/21/2000WO2000054769A1 Protease inhibitors
09/21/2000WO2000054767A1 Use of lipoxin compounds for inhibiting of tnf-(alfa) initiated neutrophil response
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000054761A2 Regulation of phospholipase d activity
09/21/2000WO2000054758A2 Method for delivering benzidine prostaglandins by inhalation
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000040583A3 Imidazo[4,5-c]-pyridine-4-on-derivatives
09/21/2000WO2000040225A3 Inhibition of tnf activity
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000DE19910697A1 Natural medicament useful for treating inflammation, rheumatism or skin disease, obtained from Aloe genus plants, honey and ethanol
09/21/2000CA2768688A1 Regulation of phospholipase d activity
09/21/2000CA2747376A1 Use of lipoxin compounds for inhibiting of tnf-(alpha) initiated neutrophil response
09/21/2000CA2675416A1 Lipoxin compounds and their use
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367409A1 Metering valve
09/21/2000CA2367352A1 Amine derivatives as protease inhibitors
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367213A1 Novel antiangiogenic peptides
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364637A1 50 human secreted proteins
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364568A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2361819A1 Amide derivatives
09/21/2000CA2361503A1 Corticosteroid formulation
09/20/2000EP1036178A1 Identification of lysolipid receptors involved in inflammatory response
09/20/2000EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
09/20/2000EP1036062A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
09/20/2000EP1036059A1 Adamantane derivatives
09/20/2000EP1036058A1 Adamantane derivatives
09/20/2000EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
09/20/2000EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
09/20/2000EP1035846A2 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000EP0874805B1 Phenylacetamide derivatives
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000CN1267306A Cyclopeptide derivs. as adhesion inhibitors
09/20/2000CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity
09/20/2000CN1267215A Pharmacetical compositions contg. effervescent acid-base couple
09/20/2000CN1266705A Chinese-medicinal pills for treating rheumatism and preparing process thereof
09/20/2000CN1266699A Anti-infectious antipyretic and antalgic medicine
09/20/2000CN1266696A Chinese medicine for making lumbus stronger and consolidating vital energy of kidney
09/20/2000CN1056615C Difluoro pentapeptide deriv. antiinflammatory agent
09/20/2000CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same
09/20/2000CN1056608C Pseudodipeptide product having imidazole group and applications
09/20/2000CN1056605C Compounds as selective human NK 3-receptor antagonists and their use
09/20/2000CN1056602C Esters and amides as PLAZ inhibitors
1 ... 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 ... 1272